What is Core Laboratories Inc. worth?
With the base-case assumptions below, a discounted cash flow model on Core Laboratories Inc.'s reported free cash flow gives $7.00 per share. The share price was $10.39 on September 25, 2026, 48% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | -2.0% | 10.0% | $3.58 | -66% |
| Base | 3.0% | 9.0% | $7.00 | -33% |
| Bull | 8.0% | 8.0% | $13.38 | +29% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $9.41 | $10.14 | $11.03 | $12.15 | $13.58 |
| 8.0% | $7.62 | $8.09 | $8.65 | $9.32 | $10.14 |
| 9.0% | $6.30 | $6.63 | $7.00 | $7.43 | $7.95 |
| 10.0% | $5.30 | $5.53 | $5.79 | $6.09 | $6.43 |
| 11.0% | $4.51 | $4.68 | $4.87 | $5.08 | $5.32 |
Where the presets come from
Base: years 1 to 5 grow at Core Laboratories Inc.'s revenue growth rate over the last 4 fiscal years (2.9% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions